The viral variability of 5 hepatitis C virus (HCV)-infected immunocompromised patients was analyzed and compared with that in isolates from immunocompetent subjects. The patients were followed longitudinally with regard to changes in hypervariable region 1 (HVR1) of HCV using a direct DNA sequencing approach. For the immunocompromised patients, viral nucleotide sequence variability was markedly lower than in immunocompetent HCV-positive patients. For 1 agammaglobulinemic patient and 1 AIDS patient, no variation in the major amino acid sequence of HCV HVR1 could be observed, while another agammaglobulinemic patient exhibited transient variations and amino acid substitutions despite the lack of functioning humoral immune response. The study supports the general hypothesis of humoral immune selection as the main force of sequence variation in the HVR1 region but suggests that other selection mechanisms may contribute to modulation of the composition of the viral population.
The viral variability of 5 hepatitis C virus (HCV)-infected immunocompromised patients was
analyzed and compared with that in isolates from immunocompetent subjects. The patients were followed longitudinally with regard to changes in hypervariable region 1 (HVR1) of HCV using a direct DNA sequencing approach. For the immunocompromised patients, viral nucleotide sequence variability was markedly lower than in immunocompetent HCV-positive patients. For 1 agammaglobulinemic patient and 1 AIDS patient, no variation in the major amino acid sequence of HCV HVR1 could be observed, while another agammaglobulinemic patient exhibited transient variations and amino acid substitutions despite the lack of functioning humoral immune response. The study supports the general hypothesis of humoral immune selection as the main force of sequence variation in the HVR1 region but suggests that other selection mechanisms may contribute to modulation of the composition of the viral population.
Hepatitis C virus (HCV) is the major causative agent of non-
The 27-aa hypervariable region 1 (HVR1) in the N-terminal part of the putative envelope protein of HCV encoded by the A, non-B posttransfusion hepatitis and has a positive singlestranded RNA of Ç9.4 kb with a quasispecies nature [1] . An E2 gene shows a high degree of variation and heterogeneity and appears to contain major neutralizing epitopes [3, 4] . The isolate of hepatitis C is most accurately described as a population of closely related viral variants, for which, in theory, each immune response is generally regarded as the major force driving the selection of new HVR1 variants of HCV [4] [5] [6] . Lack genome can be unique due to the error-prone nature of the viral RNA-directed RNA polymerase. Both positive and negative of variation in HVR1 in the absence of a humoral immune response has been reported by Kumar et al. [7] , but data were selection as well as random sampling events will influence the viral population and the resulting consensus sequence [2] .
limited to 1 patient, and the cloning approach used in the study has drawbacks when the dynamics of HVR1 are to be studied [8, 9] . Antigenic variation in the absence of immune selection Received 16 April 1996; revised 7 November 1996. can occur in RNA viruses, as pointed out by Domingo et al. to the N-terminal core protein as described [12] . In addition, anti-
HCV-specific antibodies to a region in HVR1 that has been sug- reactivity was done essentially on the basis of a protocol described not determined; CAH, chronic active hepatitis. Anti-HCV was determined [14] . Only samples with reactivity exceeding the mean absorbance using second-generation ELISA or RIBA (see Materials and Methods). Genotyping was done as described [8] .
at 405 nm of anti-HCV-negative serum by ú8 SD were considered reactive.
population-based direct solid-phase sequencing approach was Results used [8] . The dynamics of the HVR1 consensus sequence was followed in 5 patients with chronic HCV infection in whom the Immunocompromised patients with chronic HCV infection ability to mount a functional immune response was impaired.
were analyzed longitudinally in a retrospective study by a direct sequencing strategy. A control group of 5 immunocompetent patients was analyzed in parallel, and the results are summaMaterials and Methods rized in table 2.
occur in a slightly more scattered pattern than the more clusdefinition) at the time of this study (1992) (1993) . Five immunocompetent HCV-positive patients from a previous tered appearance of substitutions between aa 395 and 407 seen study (patients 2ic, 8ic, 11ic, 13ic, and 20ic) were used for comparin, for example, immunocompetent patient 11ic and as reported ison [8] . None of the patients had received any antiviral therapy by others [4, 6] .
before or during the study. The characteristics of the 10 patients
For patient 2, the predicted major amino acid consensus are summarized in table 1. sequence was identical at the investigated time points. HowSample preparation, RNA extraction, RT-PCR, primers, and ever, the fact that minor silent polymorphic sites appeared and direct solid-phase sequencing reactions were as described [8] .
disappeared at the nucleotide level indicate that there were also Briefly, after seminested RT-PCR (with one of the primers biotinshifts in the HCV population equilibrium in this patient. core protein (data not shown). The lack of humoral immune system. Thus, it is likely that the T helper cell-dependent anti-HCV antibody function was severely suppressed in these AIDS response was further evidenced by negative tests for anti-HCV antibodies to designed autologous 18-mer peptides of HVR1 patients. The limited number of agammaglobulinemic patients and (A 405 /cutoff £1; table 2).
Patients 3-5, with concurrent HIV-1 and HCV infection, AIDS patients did not allow reliable statistical analysis for these 2 groups. However, both groups displayed markedly were analyzed over 63, 36, and 35 weeks, respectively; the results are summarized in table 2 and depicted in detail in fewer major sequence nucleotide variations per genome site and year than in the 5 immunocompetent patients. The correfigure 1B. The heterogeneity was notably restricted, and the amino acid variation over time was low. Patient 3 showed sponding amino acid substitutions per genome site and year also showed a lower trend in immunocompromised patients. limited heterogeneity at the first two time points and a gradual substitution (SerjAla) of the amino acid consensus sequence In addition, the 2 immunocompetent patients assayed for reactivity to autologous peptides ( figure 1C ) showed higher reactivat 1 position during the 63-week period. Patient 4 showed slightly increasing heterogeneity, both at the nucleotide and ity than did the immunocompromised patients (table 2) . the corresponding amino acid levels, at the second time point (after 36 weeks) and a substitution of the major amino acid Discussion consensus sequence (ProjThr) at 1 position. No variation or heterogeneity was observed in patient 5.
Despite the potentially high mutation rate and variability of RNA viruses, changes in the consensus sequence of a viral Anti-HCV antibody tests (ELISA, RIBA) were positive for all samples. Titers of antibodies to an immunodominant region population will occur only if some selection mechanism acts on the population and causes a shift in the population equilibrium. in the conserved HCV core protein also gave positive results, but the levels were Ç3-5 times lower at the last time points for Selection against a less competitive variant or selection for a beneficial mutation in another part of the genome, to which a patients 3 and 4 (data not shown). The presence of antibodies to the HVR1 region was assayed using autologous 18-mer pepdifferent HVR1 sequence variant is linked, will result in a new major HVR1 nucleotide consensus sequence. Such an accomtides (figure 1B). In patients 3 and 4, only weak reactivity was found (absorbance/cutoff £2). In patient 5, no reactivity was panying substitution in the HVR1 could be either silent or nonsilent, as opposed to the nonsilent nucleotide substitutions found. In addition, the corresponding CD4 cell values (figure 1B) further indicated the deterioration of the patient's immune expected and observed when immune selection is acting di- rectly on HVR1 [3, 8] and as shown here with the control group. study, the strategy was to sequence a limited number of cloned RT-PCR products of HVR1. From our data, one may speculate that another, nonhumoral selection mechanism is responsible for the observed variation Unless large numbers of clones are analyzed, only the preof the HCV population in the immunocompromised patients; dominant variants will be revealed. With a direct sequencing this idea is based primarily on the randomly scattered silent approach, a single analysis yields a consensus sequence that and nonsilent nucleotide variations found in the agammaglobureflects the total HCV population and detects minor variants linemic patients but also is supported by analysis of data from down to 10% of the total population [8, 9] . The virus population the AIDS patients.
could be a mosaic of many different quasispecies, and the consensus sequence may not necessarily be representative of A cellular immune-driven selection pressure has recently the most abundant strain. However, due to the very low or been demonstrated by the existence of HCV escape mutants nonexistent polymorphisms found in our 5 immunocompromin relation to cytotoxic T cell epitopes [15] . In addition, as ised patients, a rather unambiguous description of the virus pointed out previously [2] , variation at major antigenic sites population was obtained. This also allowed the design, on the can occur in the absence of any immune selection by a variety basis of direct sequencing, of autologous peptides for HVR1. of different mechanisms. Recently, Kumar et al. [7] reported on the invariant sequence of HVR1 in 1 agammaglobulinemic
In conclusion, we present data that support the general hypothesis of humoral immune selection as the main driving force patient followed for ú2 years without detection of any minor variants or shifts in population equilibrium. Of note in that of HVR1 variability and that show that absence of a functional
